O	0	5	TRADD	TRADD	NN	B-NP
O	6	12	domain	domain	NN	I-NP
O	13	15	of	of	IN	B-PP
O	16	23	Epstein	Epstein	NNP	B-NP
O	23	24	-	-	HYPH	I-NP
O	24	28	Barr	Barr	NNP	I-NP
O	29	34	virus	virus	NN	I-NP
O	35	47	transforming	transform	VBG	B-VP
O	48	55	protein	protein	NN	B-NP
O	56	60	LMP1	LMP1	NN	I-NP
O	61	63	is	be	VBZ	B-VP
O	64	73	essential	essential	JJ	B-ADJP
O	74	77	for	for	IN	B-PP
O	78	86	inducing	induce	VBG	B-VP
O	87	102	immortalization	immortalization	NN	B-NP
O	103	106	and	and	CC	O
O	107	118	suppressing	suppress	VBG	B-VP
O	119	129	senescence	senescence	NN	B-NP
O	130	132	of	of	IN	B-PP
O	133	140	primary	primary	JJ	B-NP
O	141	147	rodent	rodent	JJ	I-NP
B-Cell	148	159	fibroblasts	fibroblast	NNS	I-NP
O	159	160	.	.	.	O

O	162	170	Mutation	Mutation	NN	B-NP
O	171	179	analysis	analysis	NN	I-NP
O	180	182	of	of	IN	B-PP
O	183	189	latent	latent	JJ	B-NP
O	190	198	membrane	membrane	NN	I-NP
O	199	206	protein	protein	NN	I-NP
O	207	208	1	1	CD	I-NP
O	209	210	(	(	(	O
O	210	214	LMP1	LMP1	NN	B-NP
O	214	215	)	)	)	O
O	216	218	in	in	IN	B-PP
O	219	226	Epstein	Epstein	NNP	B-NP
O	226	227	-	-	HYPH	I-NP
O	227	231	Barr	Barr	NNP	I-NP
O	232	237	virus	virus	NN	I-NP
O	238	239	(	(	(	O
O	239	242	EBV	EBV	NN	B-NP
O	242	243	)	)	)	O
O	243	244	-	-	HYPH	B-VP
O	244	251	induced	induce	VBN	B-NP
B-Cell	252	253	B	B	NN	I-NP
I-Cell	253	254	-	-	HYPH	B-NP
I-Cell	254	258	cell	cell	NN	I-NP
O	259	274	immortalization	immortalization	NN	I-NP
O	275	283	revealed	reveal	VBD	B-VP
O	284	287	two	two	CD	B-NP
O	288	302	transformation	transformation	NN	I-NP
O	303	311	effector	effector	NN	I-NP
O	312	317	sites	site	NNS	I-NP
O	317	318	,	,	,	O
O	319	323	TES1	TES1	NN	B-NP
O	324	327	and	and	CC	I-NP
O	328	332	TES2	TES2	NN	I-NP
O	332	333	.	.	.	O

O	334	338	TES2	TES2	NN	B-NP
O	339	347	mediates	mediate	VBZ	B-VP
O	348	351	the	the	DT	B-NP
O	352	363	interaction	interaction	NN	I-NP
O	364	368	with	with	IN	B-PP
O	369	374	tumor	tumor	NN	B-NP
O	375	383	necrosis	necrosis	NN	I-NP
O	384	390	factor	factor	NN	I-NP
O	391	399	receptor	receptor	NN	I-NP
O	399	400	-	-	HYPH	O
O	400	410	associated	associate	VBN	B-NP
O	411	416	death	death	NN	I-NP
O	417	423	domain	domain	NN	I-NP
O	424	431	protein	protein	NN	I-NP
O	432	433	(	(	(	O
O	433	438	TRADD	TRADD	NN	B-NP
O	438	439	)	)	)	O
O	440	443	and	and	CC	O
O	444	449	plays	play	VBZ	B-VP
O	450	451	a	a	DT	B-NP
O	452	455	key	key	JJ	I-NP
O	456	460	role	role	NN	I-NP
O	461	463	in	in	IN	B-PP
O	464	479	transactivating	transactivate	VBG	B-VP
O	480	482	NF	NF	NN	B-NP
O	482	483	-	-	HYPH	B-NP
O	483	488	kappa	kappa	NN	I-NP
O	489	490	B	B	NN	I-NP
O	491	494	and	and	CC	O
O	495	497	AP	AP	NN	B-NP
O	497	498	-	-	HYPH	B-NP
O	498	499	1	1	CD	I-NP
O	499	500	.	.	.	O

O	501	512	Recombinant	Recombinant	JJ	B-NP
O	513	516	EBV	EBV	NN	I-NP
O	517	527	containing	contain	VBG	B-VP
O	528	532	LMP1	LMP1	NN	B-NP
O	533	537	with	with	IN	B-PP
O	538	542	TES2	TES2	NN	B-NP
O	543	550	deleted	delete	VBN	B-VP
O	551	558	induces	induce	VBZ	B-VP
O	559	560	a	a	DT	B-NP
O	561	568	limited	limited	JJ	I-NP
O	569	582	proliferation	proliferation	NN	I-NP
O	583	585	of	of	IN	B-PP
B-Cell	586	587	B	B	NN	B-NP
I-Cell	588	593	cells	cell	NNS	I-NP
O	593	594	.	.	.	O

O	595	598	The	The	DT	B-NP
O	599	606	present	present	JJ	I-NP
O	607	612	study	study	NN	I-NP
O	613	618	shows	show	VBZ	B-VP
O	619	623	that	that	IN	B-SBAR
O	624	625	a	a	DT	B-NP
O	626	632	mutant	mutant	NN	I-NP
O	633	637	with	with	IN	B-PP
O	638	640	an	an	DT	B-NP
O	641	645	LMP1	LMP1	NN	I-NP
O	646	650	site	site	NN	I-NP
O	650	651	-	-	HYPH	B-NP
O	651	659	specific	specific	JJ	I-NP
O	660	668	mutation	mutation	NN	I-NP
O	669	671	at	at	IN	B-PP
O	672	676	TES2	TES2	NN	B-NP
O	676	677	,	,	,	O
O	678	682	LMP1	LMP1	NN	B-NP
O	682	683	(	(	(	O
O	683	688	TRADD	TRADD	NN	B-NP
O	688	689	)	)	)	O
O	689	690	,	,	,	O
O	691	700	initially	initially	RB	B-ADVP
O	701	711	stimulates	stimulate	VBZ	B-VP
B-Cell	712	716	cell	cell	NN	B-NP
O	717	723	growth	growth	NN	I-NP
O	724	727	and	and	CC	O
O	728	741	significantly	significantly	RB	B-VP
O	742	749	extends	extend	VBZ	I-VP
O	750	753	the	the	DT	B-NP
O	754	758	life	life	NN	I-NP
O	759	763	span	span	NN	I-NP
O	764	766	of	of	IN	B-PP
B-Cell	767	770	MEF	MEF	NN	B-NP
O	770	771	.	.	.	O

O	772	779	However	However	RB	B-ADVP
O	779	780	,	,	,	O
O	781	783	it	it	PRP	B-NP
O	784	786	is	be	VBZ	B-VP
O	787	790	not	not	RB	O
O	791	801	sufficient	sufficient	JJ	B-ADJP
O	802	805	for	for	IN	B-PP
O	806	809	the	the	DT	B-NP
O	810	825	immortalization	immortalization	NN	I-NP
O	826	828	of	of	IN	B-PP
B-Cell	829	832	MEF	MEF	NN	B-NP
O	832	833	,	,	,	O
O	834	837	and	and	CC	O
B-Cell	838	841	MEF	MEF	NN	B-NP
I-Cell	841	842	-	-	HYPH	O
I-Cell	842	846	LMP1	LMP1	NN	B-NP
I-Cell	846	847	(	(	(	O
I-Cell	847	852	TRADD	TRADD	NN	B-NP
I-Cell	852	853	)	)	)	O
I-Cell	854	859	cells	cell	NNS	B-NP
O	860	870	eventually	eventually	RB	B-ADVP
O	871	876	enter	enter	VBP	B-VP
O	877	883	growth	growth	NN	B-NP
O	884	890	arrest	arrest	NN	I-NP
O	890	891	.	.	.	O

O	892	899	Further	Further	JJ	B-NP
O	900	908	analysis	analysis	NN	I-NP
O	909	916	reveals	reveal	VBZ	B-VP
O	917	921	that	that	IN	B-SBAR
O	922	930	although	although	IN	B-SBAR
O	931	935	LMP1	LMP1	NN	B-NP
O	935	936	(	(	(	O
O	936	941	TRADD	TRADD	NN	B-NP
O	941	942	)	)	)	O
O	943	951	promotes	promote	VBZ	B-VP
B-Cell	952	956	cell	cell	NN	B-NP
O	957	963	growth	growth	NN	I-NP
O	963	964	,	,	,	O
O	965	967	it	it	PRP	B-NP
O	968	972	does	do	VBZ	B-VP
O	973	976	not	not	RB	I-VP
O	977	984	prevent	prevent	VB	I-VP
O	985	988	the	the	DT	B-NP
O	989	997	eventual	eventual	JJ	I-NP
O	998	1003	onset	onset	NN	I-NP
O	1004	1006	of	of	IN	B-PP
O	1007	1017	senescence	senescence	NN	B-NP
O	1018	1021	and	and	CC	O
O	1022	1025	the	the	DT	B-NP
O	1026	1036	expression	expression	NN	I-NP
O	1037	1039	of	of	IN	B-PP
B-Cancer	1040	1045	tumor	tumor	NN	B-NP
O	1046	1056	suppressor	suppressor	NN	I-NP
O	1057	1060	p16	p16	NN	I-NP
O	1060	1061	(	(	(	O
O	1061	1066	Ink4a	Ink4a	NN	B-NP
O	1066	1067	)	)	)	O
O	1067	1068	.	.	.	O

